[Malignant acanthosis nigricans].
D000052:Acanthosis Nigricans / Q000188:drug therapy / Q000209:etiology*; D002288:Adenocarcinoma, Mucinous / Q000150:complications*; D003533:Cyproheptadine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000209:etiology; D012186:Retroperitoneal Neoplasms / Q000556:secondary; D013274:Stomach Neoplasms / Q000150:complications*
D003533:Cyproheptadine
Acanthosis nigricans maligna.